nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—MT1A—connective tissue—age related macular degeneration	0.0219	0.104	CbGeAlD
Cisplatin—MT2A—eye—age related macular degeneration	0.0189	0.0898	CbGeAlD
Cisplatin—MT2A—connective tissue—age related macular degeneration	0.0182	0.0865	CbGeAlD
Cisplatin—ATP7A—connective tissue—age related macular degeneration	0.0158	0.0749	CbGeAlD
Cisplatin—ABCC6—eye—age related macular degeneration	0.015	0.0713	CbGeAlD
Cisplatin—ABCC6—retina—age related macular degeneration	0.0149	0.0707	CbGeAlD
Cisplatin—ABCC6—connective tissue—age related macular degeneration	0.0145	0.0687	CbGeAlD
Cisplatin—GSTM1—connective tissue—age related macular degeneration	0.0131	0.0624	CbGeAlD
Cisplatin—ABCC5—retina—age related macular degeneration	0.0101	0.048	CbGeAlD
Cisplatin—NQO1—eye—age related macular degeneration	0.00956	0.0454	CbGeAlD
Cisplatin—NQO1—retina—age related macular degeneration	0.00947	0.045	CbGeAlD
Cisplatin—NQO1—connective tissue—age related macular degeneration	0.00921	0.0437	CbGeAlD
Cisplatin—GSTP1—eye—age related macular degeneration	0.00854	0.0405	CbGeAlD
Cisplatin—MPO—connective tissue—age related macular degeneration	0.00846	0.0402	CbGeAlD
Cisplatin—GSTP1—retina—age related macular degeneration	0.00846	0.0402	CbGeAlD
Cisplatin—GSTP1—connective tissue—age related macular degeneration	0.00823	0.0391	CbGeAlD
Cisplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—age related macular degeneration	0.00478	0.00605	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—F13B—age related macular degeneration	0.00466	0.0059	CbGpPWpGaD
Cisplatin—SOD1—Platelet degranulation—CD36—age related macular degeneration	0.00458	0.0058	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—SERPING1—age related macular degeneration	0.00438	0.00555	CbGpPWpGaD
Cisplatin—SOD1—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00436	0.00553	CbGpPWpGaD
Cisplatin—GSTM1—NRF2 pathway—SQSTM1—age related macular degeneration	0.00433	0.00549	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00425	0.00538	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—CRP—age related macular degeneration	0.0042	0.00532	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—CCL2—age related macular degeneration	0.00396	0.00502	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—SQSTM1—age related macular degeneration	0.00392	0.00496	CbGpPWpGaD
Cisplatin—PTGS2—connective tissue—age related macular degeneration	0.00384	0.0182	CbGeAlD
Cisplatin—SOD1—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00383	0.00485	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—RAD51B—age related macular degeneration	0.0038	0.00481	CbGpPWpGaD
Cisplatin—PTGS2—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0037	0.00468	CbGpPWpGaD
Cisplatin—GSTP1—NRF2 pathway—SQSTM1—age related macular degeneration	0.00368	0.00467	CbGpPWpGaD
Cisplatin—NQO1—NRF2 pathway—SQSTM1—age related macular degeneration	0.00359	0.00455	CbGpPWpGaD
Cisplatin—MT2A—Immune System—C9—age related macular degeneration	0.00359	0.00454	CbGpPWpGaD
Cisplatin—PTGS2—S1P1 pathway—KDR—age related macular degeneration	0.00354	0.00449	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—SLC16A8—age related macular degeneration	0.00353	0.00447	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—CCL2—age related macular degeneration	0.00346	0.00438	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00334	0.00423	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—NMNAT1—age related macular degeneration	0.00323	0.0041	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00315	0.00399	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CFI—age related macular degeneration	0.00311	0.00394	CbGpPWpGaD
Cisplatin—ABCC5—NRF2 pathway—SQSTM1—age related macular degeneration	0.00309	0.00391	CbGpPWpGaD
Cisplatin—ATP7B—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00295	0.00373	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00292	0.0037	CbGpPWpGaD
Cisplatin—ABCG2—HIF-2-alpha transcription factor network—KDR—age related macular degeneration	0.00292	0.0037	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CFHR3—age related macular degeneration	0.00289	0.00366	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00289	0.00366	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—ELOVL4—age related macular degeneration	0.00283	0.00358	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00275	0.00348	CbGpPWpGaD
Cisplatin—CYP4A11—NRF2 pathway—SQSTM1—age related macular degeneration	0.00268	0.00339	CbGpPWpGaD
Cisplatin—MT2A—Immune System—C2—age related macular degeneration	0.00258	0.00326	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00253	0.0032	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00251	0.00317	CbGpPWpGaD
Cisplatin—ATP7A—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00251	0.00317	CbGpPWpGaD
Cisplatin—ABCB1—retina—age related macular degeneration	0.00244	0.0116	CbGeAlD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.0024	0.00304	CbGpPWpGaD
Cisplatin—ABCC6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.0024	0.00304	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.0024	0.00304	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—SLC16A8—age related macular degeneration	0.00228	0.00289	CbGpPWpGaD
Cisplatin—ABCC3—NRF2 pathway—SQSTM1—age related macular degeneration	0.00228	0.00288	CbGpPWpGaD
Cisplatin—CYP4A11—PPARA activates gene expression—CD36—age related macular degeneration	0.00225	0.00285	CbGpPWpGaD
Cisplatin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.00224	0.00284	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00223	0.00283	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00223	0.00283	CbGpPWpGaD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00221	0.0028	CbGpPWpGaD
Cisplatin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—age related macular degeneration	0.0022	0.00279	CbGpPWpGaD
Cisplatin—SOD1—Platelet degranulation—VEGFA—age related macular degeneration	0.00218	0.00276	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CFH—age related macular degeneration	0.00215	0.00273	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00215	0.00272	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CFB—age related macular degeneration	0.00209	0.00265	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—NMNAT1—age related macular degeneration	0.00208	0.00264	CbGpPWpGaD
Cisplatin—SOD1—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00208	0.00263	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00203	0.00257	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00202	0.00256	CbGpPWpGaD
Cisplatin—PTGS2—S1P1 pathway—VEGFA—age related macular degeneration	0.00195	0.00247	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00185	0.00234	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ELOVL4—age related macular degeneration	0.00182	0.00231	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—SQSTM1—age related macular degeneration	0.0018	0.00229	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—SKIV2L—age related macular degeneration	0.00177	0.00225	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—B3GLCT—age related macular degeneration	0.00177	0.00225	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RDH8—age related macular degeneration	0.00177	0.00225	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NMNAT1—age related macular degeneration	0.00177	0.00225	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—NMNAT1—age related macular degeneration	0.00177	0.00224	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—NMNAT1—age related macular degeneration	0.00173	0.00219	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00165	0.00209	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00165	0.00209	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00164	0.00208	CbGpPWpGaD
Cisplatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—age related macular degeneration	0.00161	0.00204	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RPE65—age related macular degeneration	0.00155	0.00196	CbGpPWpGaD
Cisplatin—XDH—Metabolism—NMNAT1—age related macular degeneration	0.00155	0.00196	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ELOVL4—age related macular degeneration	0.00155	0.00196	CbGpPWpGaD
Cisplatin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.00152	0.00192	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ELOVL4—age related macular degeneration	0.00151	0.00191	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—NMNAT1—age related macular degeneration	0.00148	0.00188	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—SLC16A8—age related macular degeneration	0.00147	0.00186	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00146	0.00186	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—VEGFA—age related macular degeneration	0.00139	0.00177	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ELOVL4—age related macular degeneration	0.00135	0.00171	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00131	0.00165	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00131	0.00165	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ELOVL4—age related macular degeneration	0.0013	0.00164	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—NMNAT1—age related macular degeneration	0.00129	0.00163	CbGpPWpGaD
Cisplatin—MT2A—Immune System—SQSTM1—age related macular degeneration	0.00128	0.00162	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00127	0.00161	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00126	0.0016	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ABCA4—age related macular degeneration	0.00125	0.00158	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—SLC16A8—age related macular degeneration	0.00125	0.00158	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—SLC16A8—age related macular degeneration	0.00122	0.00154	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00119	0.0015	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—LIPC—age related macular degeneration	0.00117	0.00148	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00114	0.00145	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00114	0.00144	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00114	0.00144	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00113	0.00143	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ELOVL4—age related macular degeneration	0.00113	0.00143	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—CETP—age related macular degeneration	0.00113	0.00143	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00112	0.00142	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00112	0.00142	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.0011	0.0014	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NMNAT1—age related macular degeneration	0.00109	0.00139	CbGpPWpGaD
Cisplatin—XDH—Metabolism—SLC16A8—age related macular degeneration	0.00109	0.00138	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RHO—age related macular degeneration	0.00109	0.00138	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00108	0.00137	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00107	0.00135	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—CD36—age related macular degeneration	0.00105	0.00133	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—SLC16A8—age related macular degeneration	0.00105	0.00133	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00104	0.00132	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00101	0.00127	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000968	0.00123	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000963	0.00122	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ELOVL4—age related macular degeneration	0.000957	0.00121	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.000946	0.0012	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—SLC16A8—age related macular degeneration	0.000907	0.00115	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.000892	0.00113	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000887	0.00112	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.000881	0.00112	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD36—age related macular degeneration	0.000858	0.00109	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000855	0.00108	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.000841	0.00107	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—VEGFA—age related macular degeneration	0.000839	0.00106	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NMNAT1—age related macular degeneration	0.000836	0.00106	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TLR4—age related macular degeneration	0.000822	0.00104	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000813	0.00103	CbGpPWpGaD
Cisplatin—MT2A—Immune System—C3—age related macular degeneration	0.000813	0.00103	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CRP—age related macular degeneration	0.000773	0.00098	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—SLC16A8—age related macular degeneration	0.000771	0.000977	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.000755	0.000956	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NMNAT1—age related macular degeneration	0.000755	0.000956	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—LIPC—age related macular degeneration	0.000752	0.000952	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000748	0.000948	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NMNAT1—age related macular degeneration	0.000747	0.000946	CbGpPWpGaD
Cisplatin—MT2A—Immune System—TLR4—age related macular degeneration	0.000741	0.000939	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—VEGFA—age related macular degeneration	0.000732	0.000928	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ELOVL4—age related macular degeneration	0.000731	0.000926	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CETP—age related macular degeneration	0.000725	0.000919	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CCL2—age related macular degeneration	0.000706	0.000894	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000689	0.000872	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RDH8—age related macular degeneration	0.000687	0.000871	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NMNAT1—age related macular degeneration	0.000687	0.000871	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CST3—age related macular degeneration	0.000679	0.000861	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000677	0.000858	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—CD36—age related macular degeneration	0.000676	0.000857	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ELOVL4—age related macular degeneration	0.00066	0.000836	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000653	0.000828	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ELOVL4—age related macular degeneration	0.000653	0.000827	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000645	0.000817	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—LIPC—age related macular degeneration	0.000639	0.00081	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—LIPC—age related macular degeneration	0.000623	0.000789	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CETP—age related macular degeneration	0.000617	0.000781	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000614	0.000778	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000614	0.000778	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFBR1—age related macular degeneration	0.00061	0.000773	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000605	0.000766	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CETP—age related macular degeneration	0.000601	0.000761	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RPE65—age related macular degeneration	0.000601	0.000761	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—APOE—age related macular degeneration	0.000597	0.000756	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SLC16A8—age related macular degeneration	0.000589	0.000746	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NMNAT1—age related macular degeneration	0.000576	0.000729	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000561	0.00071	CbGpPWpGaD
Cisplatin—XDH—Metabolism—LIPC—age related macular degeneration	0.000559	0.000708	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000555	0.000703	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NMNAT1—age related macular degeneration	0.000553	0.000701	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CETP—age related macular degeneration	0.000539	0.000683	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—LIPC—age related macular degeneration	0.000536	0.000678	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000533	0.000676	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SLC16A8—age related macular degeneration	0.000532	0.000674	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SLC16A8—age related macular degeneration	0.000526	0.000667	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CETP—age related macular degeneration	0.000517	0.000655	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000514	0.000651	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.000511	0.000648	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ELOVL4—age related macular degeneration	0.000503	0.000637	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—VEGFA—age related macular degeneration	0.000499	0.000632	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ABCA4—age related macular degeneration	0.000484	0.000614	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ELOVL4—age related macular degeneration	0.000484	0.000613	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000466	0.000591	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—LIPC—age related macular degeneration	0.000464	0.000588	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000453	0.000574	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00045	0.00057	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CETP—age related macular degeneration	0.000448	0.000568	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.000443	0.000561	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CD36—age related macular degeneration	0.000436	0.000552	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RHO—age related macular degeneration	0.000421	0.000534	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.000408	0.000517	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC16A8—age related macular degeneration	0.000406	0.000514	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—LIPC—age related macular degeneration	0.000395	0.0005	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000393	0.000498	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC16A8—age related macular degeneration	0.00039	0.000494	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—APOE—age related macular degeneration	0.000384	0.000487	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.000381	0.000483	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CETP—age related macular degeneration	0.000381	0.000483	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CD36—age related macular degeneration	0.000371	0.000469	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CD36—age related macular degeneration	0.000361	0.000457	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000357	0.000452	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000346	0.000439	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000333	0.000422	CbGpPWpGaD
Cisplatin—ABCC5—Disease—APOE—age related macular degeneration	0.000327	0.000414	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—APOE—age related macular degeneration	0.000327	0.000414	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CD36—age related macular degeneration	0.000324	0.00041	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—APOE—age related macular degeneration	0.000319	0.000404	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CD36—age related macular degeneration	0.000311	0.000393	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000309	0.000391	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000308	0.00039	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000303	0.000384	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—LIPC—age related macular degeneration	0.000302	0.000382	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000298	0.000377	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CETP—age related macular degeneration	0.000291	0.000369	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000288	0.000364	CbGpPWpGaD
Cisplatin—XDH—Metabolism—APOE—age related macular degeneration	0.000286	0.000362	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—APOE—age related macular degeneration	0.000274	0.000347	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—LIPC—age related macular degeneration	0.000272	0.000345	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00027	0.000342	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—LIPC—age related macular degeneration	0.000269	0.000341	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CD36—age related macular degeneration	0.000269	0.000341	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000269	0.00034	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CST3—age related macular degeneration	0.000263	0.000334	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CETP—age related macular degeneration	0.000263	0.000333	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CETP—age related macular degeneration	0.00026	0.000329	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CCL2—age related macular degeneration	0.000252	0.000319	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000238	0.000302	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—APOE—age related macular degeneration	0.000238	0.000301	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFBR1—age related macular degeneration	0.000237	0.0003	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CD36—age related macular degeneration	0.000229	0.00029	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000218	0.000277	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—LIPC—age related macular degeneration	0.000208	0.000263	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—APOE—age related macular degeneration	0.000202	0.000256	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CETP—age related macular degeneration	0.0002	0.000254	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—LIPC—age related macular degeneration	0.0002	0.000253	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CETP—age related macular degeneration	0.000193	0.000244	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000179	0.000227	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CD36—age related macular degeneration	0.000175	0.000222	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000158	0.0002	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CD36—age related macular degeneration	0.000158	0.0002	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CD36—age related macular degeneration	0.000156	0.000198	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—APOE—age related macular degeneration	0.000154	0.000195	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000147	0.000186	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CETP—age related macular degeneration	0.000142	0.00018	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—APOE—age related macular degeneration	0.000139	0.000176	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—APOE—age related macular degeneration	0.000138	0.000175	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000137	0.000174	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000133	0.000168	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APOE—age related macular degeneration	0.000127	0.000161	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CD36—age related macular degeneration	0.00012	0.000153	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CD36—age related macular degeneration	0.000116	0.000147	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—APOE—age related macular degeneration	0.000106	0.000135	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—APOE—age related macular degeneration	0.000102	0.000129	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CD36—age related macular degeneration	8.53e-05	0.000108	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CD36—age related macular degeneration	7.97e-05	0.000101	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APOE—age related macular degeneration	7.53e-05	9.54e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APOE—age related macular degeneration	7.03e-05	8.91e-05	CbGpPWpGaD
